ZeClinics receives €1.87M funding in the latest round of the Horizon2020 SME Instrument Phase 2

by ZeClinics

The grant will allow ZeClinics to develop, and accelerate the commercialization, of one of our flagship products: ZeCardio. A predictive system cardiovascular impact analysis during the drug discovery...

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palex and Duomed to create the first tru...

by Palex Medical

Palex Medical has announced the execution of a put option agreement fo...

Photos Stream